0000950103-25-013417.txt : 20251021 0000950103-25-013417.hdr.sgml : 20251021 20251021080017 ACCESSION NUMBER: 0000950103-25-013417 CONFORMED SUBMISSION TYPE: SCHEDULE 13G/A PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20251021 DATE AS OF CHANGE: 20251021 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: Innate Pharma SA CENTRAL INDEX KEY: 0001598599 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 STATE OF INCORPORATION: I0 FISCAL YEAR END: 1231 LEGAL ENTITY IDENTIFIER: 9695002Y8420ZB8HJE29 FILING VALUES: FORM TYPE: SCHEDULE 13G/A SEC ACT: 1934 Act SEC FILE NUMBER: 005-91173 FILM NUMBER: 251405386 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 117 AVENUE DE LUMINY STREET 2: BP 30191 CITY: MARSEILLE NON US STATE TERRITORY: FRANCE PROVINCE COUNTRY: I0 ZIP: 13009 BUSINESS PHONE: 33430303030 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: 117 AVENUE DE LUMINY STREET 2: BP 30191 CITY: MARSEILLE NON US STATE TERRITORY: FRANCE PROVINCE COUNTRY: I0 ZIP: 13009 FORMER COMPANY: FORMER CONFORMED NAME: Innate Pharma, SA DATE OF NAME CHANGE: 20140129 FILED BY: COMPANY DATA: COMPANY CONFORMED NAME: NOVO NORDISK A S CENTRAL INDEX KEY: 0000353278 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences EIN: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: SCHEDULE 13G/A BUSINESS ADDRESS: STREET 1: NOVO ALLE DK 2880 CITY: BAGSVAERD DENMARK STATE: G7 ZIP: 00000 BUSINESS PHONE: 4544448888 MAIL ADDRESS: STREET 1: NOVO ALLE DK 2880 CITY: BAGSVAERD DENMARK STATE: G7 ZIP: 00000 FORMER COMPANY: FORMER CONFORMED NAME: NOVO NORDISK A/S DATE OF NAME CHANGE: 19900807 FORMER COMPANY: FORMER CONFORMED NAME: NOVO INDUSTRI A S /DENMARK/ DATE OF NAME CHANGE: 19890811 SCHEDULE 13G/A 1 primary_doc.xml SCHEDULE 13G/A 0000950103-20-001698 0000353278 XXXXXXXX LIVE 1 Ordinary Shares, nominal value (euro) 0.05 per share (including ordinary shares represented by American Depositary Shares) 07/14/2025 0001598599 Innate Pharma SA 45781K105 117 Avenue de Luminy BP 30191 Marseille I0 13009 Rule 13d-1(d) Novo Nordisk A/S G7 8895649.00 0.00 8895649.00 0.00 8895649.00 N 9.65 CO Innate Pharma SA 117 Avenue de Luminy, BP 30191, Marseille, France, 13009 Novo Nordisk A/S Novo Alle 1, DK-2880, Bagsvaerd Denmark Denmark Y 8,895,649 9.65% 8,895,649 0 8,895,649 0 Y Y Y Y Y Y Novo Nordisk A/S /s/ Karsten Munk Knudsen Karsten Munk Knudsen, Chief Financial Officer 10/21/2025